Sponge derived bromotyrosines are a multifaceted class of marine bioactive compounds that are important for the chemical defense of sponges but also for drug discovery programs as well as for technical applications in the field of antifouling constituents. These compounds, which are mainly accumulated by Verongid sponges, exhibit a diverse range of bioactivities including antibiotic, cytotoxic and antifouling effects. In spite of the simple biogenetic building blocks, which consist only of brominated tyrosine and tyramine units, an impressive diversity of different compounds is obtained through different linkages between these precursors and through structural modifications of the side chains and/or aromatic rings resembling strategies that are known from combinatorial chemistry. As examples for bioactive, structurally divergent bromotyrosines psammaplin A, Aplysina alkaloids featuring aerothionin, aeroplysinin-1 and the dienone, and the bastadins, including the synthetically derived hemibastadin congeners, have been selected for this review. Whereas all of these natural products are believed to be involved in the chemical defense of sponges, some of them may also be of particular relevance to drug discovery due to their interaction with specific molecular targets in eukaryotic cells. These targets involve important enzymes and receptors, such as histone deacetylases (HDAC) and DNA methyltransferases (DNMT), which are inhibited by psammaplin A, as well as ryanodine receptors that are targeted by bastadine type compounds. The hemibastadins such as the synthetically derived dibromohemibastadin are of particular interest due to their antifouling activity. For the latter, a phenoloxidase which catalyzes the bioglue formation needed for firm attachment of fouling organisms to a given substrate was identified as a molecular target. The Aplysina alkaloids finally provide a vivid example for dynamic wound induced bioconversions of natural products that generate highly efficient chemical weapons precisely when and where needed.
The fact that marine ecosystems cover over 70 % of the surface of the earth and contain about 95 % of the total biosphere, has stimulated natural product chemists for several decades now to embark on bioprospection for new metabolites and drug candidates. The remarkable diversity of natural products reported from marine organisms is due to long evolutionary processes which have favored the accumulation of strongly bioactive compounds. Seemingly primitive and morphologically defenseless organisms like sponges developed ingenious survival strategies which rely heavily on the accumulation of defensive products which protect these organisms from a multitude of stress factors that involve overgrowth by fouling organisms, and predation or invasion by pathogenic microorganisms, to name just a few. Sponges are multicellular sessile invertebrates that have successfully existed on earth for 700-800 million years and can be found in all oceans, even under the Antarctic ice cover. All sponges belong to the phylum Porifera, which is divided into three classes, the Calcarea, Hexactinellida and Demospongiae. Recently a fourth class, the Homoscleromorpha, has been established and separated from the Demospongiae by phylogenetic markers [1] . Sponges are filter-feeders which phagocytose detritus, bacteria and microalgae from the surrounding seawater. Sponges can filter up to 24,000 liters of water per 1 kg weight tissue per day [2] . Structural integrity of the sponges is maintained by siliceous or calcareous spicules and by a spongin skeleton. Interestingly, some of these simple sessile filter feeding organisms are reported to be the oldest living organisms on earth. The artic sponge Scolymastra joubini is known to live for 1,500 to 12,000 years [3] .
There is an open debate whether all natural products isolated from sponges are produced by sponges or are in fact derived from microorganisms that are inhaled though filter-feeding or that live within the sponges. In fact, a large part of the sponge biomass may consist of associated microorganisms (mainly bacteria). For the sponge Aplysina aerophoba associated microbes may account for over 40 % of the sponge biomass [4] . So far the evolutionary processes underlying sponge-microorganism associations are not well understood. Three different scenarios are hypothesized: ancient symbiosis maintained by vertical transmission of symbionts, parenteral and environmental symbiont transmission and environmental acquisition of symbionts [5] [6] [7] .
Apart from their origin and chemoecological functions spongederived metabolites are also of considerable interest for bioprospecting. Since resistance of cancer cells and of infectious microorganisms to chemotherapy is a well-known phenomenon that often causes great difficulties during chemotherapy, new drugs that may break resistance and offer alternatives to the currently available anti-cancer drugs or antibiotics are urgently needed. Marine derived compounds including those from sponges that are the most prolific source of bioactive compounds among marine invertebrates [8] have already been shown to offer new drugs for chemotherapy of cancer. Three out of seven currently FDA approved marine drugs either originate from sponges or were modeled based on sponge metabolites, underlining the potential of these compounds as drugs or drug leads. Among them Halaven ® (approved for use in the US, Canada and in the EU for the treatment of advanced mamma carcinoma) is the most notable example of a sponge inspired antitumor drug. Halaven® is a synthetic macrolide inspired by the naturally occurring halichondrin B that was originally isolated from marine sponges of the genus Halichondria, but which is also known to occur in other sponges. In addition, the nucleoside analogues Cytosar-U ® and Vira-A ® may also be mentioned that were likewise modeled based on compounds isolated from marine sponges [9] [10] [11] .
This review will focus on selected bromotyrosine derivatives from sponges, their role in chemical ecology and their pharmacological activities which make these compounds interesting for drug discovery. In spite of the rather simple structures of the bromotyrosine and bromotyramine precursors a wealth of structurally divergent metabolites is generated through different linkages between the building blocks and/or structural modifications involving the side chain and the aromatic ring thus bearing resemblances to strategies used in combinatorial chemistry. Within the group of sponges, Demospongiae of the class Verongida have been shown to be the most prolific producers of these metabolites [12, 13] . Examples of bromotyrosines used in this review have all been taken from Verongid sponges. Early reports on naturally occurring mono-and dibromotyrosine in marine invertebrates date back to 1951 [14] , when these halogenated amino acids were found as integral constituents of the coral skleroprotein gorgonin. These biogenetic precursors to all naturally occurring bromotyrosine derivatives like psammaplin A, the bastadines and the isoxazoline alkaloids from Aplysina sp. that will be covered in this review, are biosynthetically derived from phenylalanine by aromatic hydroxylation catalyzed by phenylalaninhydroxylase (PAH), and bromination presumably catalyzed by halogenases ( Figure 1 ) [15] . Bromotyrosine derivatives, however, do not only accumulate within either the cytosol or within cytosolic compartments of sponge cells, from which they can easily be extracted using organic solvents, but may also be covalently bound to sponging, as shown recently for the sponge Aplysina cavernicola [15] .
Psammaplin A Psammaplin A consists of two identical subunits, each of them composed of a bromotyrosine and a cysteine derived moiety which are linked by a disulfide bridge (Figure 1 ) [16] . This compound is primarily, but not exclusively, found in sponges from the order Verongida [17, 18] . Psammaplin A has been described from sponges of the genera Psammaplysilla [19] and Pseudoceratina [20] , both being Verongid sponges, but was also discovered as a product of two associated sponges including Poecillastra sp. and Jaspis sp., neither of which belong to the order Verongida [21] . Unique structural aspects of psammaplin A are the dense N functionalization in conjunction with S and Br atoms [20] . First described in 1987 from a Psammaplysilla sp., initial evaluation of the cytotoxic potential revealed an IC 50 value of 0.45 µM against P388 cells [22] , already indicating the pronounced biological activity of this compound. Over the last decades efforts were made to discover the various biological activities of psammaplin A, such as the antibiotic, antiviral, cytotoxic, fish deterrent and antifouling effects, whereas in the last decade detailed analyses of its pharmacologically relevant molecular targets were conducted.
Analysis of the minimal inhibitory concentrations (MIC) of psammaplin A against twenty-two different methicillin-resistant Staphylococcus aureus strains (MRSA) showed MICs ranging from 0.781 -6.25 µg/mL. The compound was demonstrated to inhibit bacterial DNA synthesis, as well as gyrase activity with IC 50 values of 2.83 and 100 µg/mL, respectively [23] . The inactivity of psammaplin A against different strains of Gram negative bacteria such as Escherischia coli, Pseudomonas aeruginosa, Salmonella typhimurium, Klebsiella oxaytoca, Enterobacter cloacae and Citrobacter freundii, as well as against a penicillin binding protein isolated from S. aureus SG511, demonstrated a narrow range of susceptible bacterial species, but a selective mode of action for the compound [23] . Oh et al., in contrast, observed no antibiotic effect of psammaplin A against S. aureus, but instead an inhibition of sortase A and B activity. Sortases are key enzymes involved in the bacterial virulence which are required for the attachment of bacteria to eukaryotic cell surface components like fibrinogen and fibrionectin. In a fibrionectin binding assay, inhibition of sortase A and B by 40 µg/mL of psammaplin A resulted in a decreased adhesion of bacterial cells to fibrionectin coated microtiter plates. Similar results were obtained using bacterial knockout mutants of sortase B and sortase A and B, implying that psammaplin A interfered with bacterial virulence. [24] . By generating a library of psammaplin A derivatives, Nicolaou et al. investigated structure activity relationships (SAR) [25] . Over 80 analogues were generated and evaluated against nine different S. aureus strains, including methicillin sensitive and resistant strains, and IC 50 values from 0.09 to >50 µg/mL were measured for the various derivatives. Parallel investigation of the general cytotoxicity against human fibroblasts and lymphocytes, however, indicated a high toxicity of the respective compounds to eukaryotic cells with IC 50 values from 1.17 -28.16 µM, respectively (0.78 and 18.7 µg/mL). Due to the toxicity of these compounds their possible use as an antibacterial agent can be ruled out.
Salam et al. observed an inhibition of hepatitis C virus NS3 nucleoside triphosphatase (NTPase)/helicase by psammaplin A in a non-competitive manner with IC 50 values 17 and 32 µM, respectively. Additionally, psammaplin A inhibited viral replication with EC 50 values of 6.1 and 6.3 µM against two subgenomic replicon cell populations derived from two different genotypes [28] . Again, when viewed against the high toxicity of the compound a possible use of psammaplin A for controlling viral diseases seems unlikely.
Beside possible anti-infective properties, initial toxicity screenings of psammaplin A against A-549, SK-OV-3, SK-MEL-2, XF-498, HCT [18] , K-562 [16] and A2780 [29] cancer cells demonstrated a pronounced cytotoxic potential of the compound as expressed by the IC 50 [15, 19, 26, 27] .
p53 independent p21 induction [20] . IC 50 values of psammaplin A amounted to 4.2 nM (+/-2.4) (HDAC inhibition) and 18.6 nM (DNMT inhibition). In the same study the authors evaluated the activity of psammaplin A in monolayers and in soft agar cell cultures against A549 cells and against MDA-MB-435 cells and reported IC 50 values of 1.15 and 2.0 µM, respectively [20] . Structure activity studies of a series of psammaplin A analogues revealed the disulfide bridge linked to two bromotyrosine end capped hydroxyimino amides as essential for inhibition of the above mentioned enzymes [20] . Similar observations were made by Ahn et al. when investigating cell proliferation of endometrial Ishikawa cancer cells. Psammaplin A was identified as an inducer of the expression of H3 and H4 histone proteins and of the cyclinedependent kinase inhibitor p21 and as a simultaneous downregulator of pRb, cyclins and CDKs expression, leading to induced cell cycle arrest. Cell cycle analysis of endometrial Ishikawa cancer cells treated with psammaplin A revealed an increased proportion of cells in the G0/G1 and G2/M phase and a decrease of cells in the S phase. Hence, the authors concluded that psammaplin A is a selective inductor of genes related to cell cycle arrest and apoptosis, associated with p53 independent p21 expression [30] . The same cell cycle interferences were observed by Pereira et al. in U937 cells, causing an acetylation of the HDAC6 marker α-tubulin [31] . Based on these investigations psammaplin A is characterized as an epigenetic modifier. When studying the inhibition of other potential epigenetic targets, including DNMT1, DNMT3A, SIRT1 and the 222 Natural Product Communications Vol. 10 (1) 2015 Niemann et al. p300/CBP HAT domain, no activity of psammaplin A was observed. Additional structure activity relationships that were elucidated using synthetic psammaplin A derivatives in an HDAC1 enzyme assay indicated that the natural product already exhibited optimized structural features. Though the disulfide bridge was identified as a key structural element essential for activity, the free thiol groups are also important for chelating the HDAC co-factor Zn + which was pointed out in this study by modeling psammaplin A into the active site of HDAC8 [32] . Out of psammaplins A, B, E and F psammaplin A was shown by Kim et al. to be one of the most potent inhibitors of HDAC1 exhibiting an IC 50 value of 0.003µM. Interestingly, in the same study a positive correlation of intracellular glutathione level and HDAC inhibition was found. When cells were glutathione-depleted with butionine sulfoxime, HDAC inhibition caused by psammaplin A was generally less pronounced giving rise to the hypothesis that intracellular conversion of psammaplin A to its corresponding monomer is responsible for the observed efficacy of the compound as an HDAC inhibitor. The cellular reduction of psammaplin A to its monomers by glutathione is therefore assumed to be a key event in the mechanism of action of this compound [33] . When tested against different HDAC isoforms, psammaplin A showed a 360 fold higher selectivity for HDAC1 over HDAC 6 and was 1000 fold less potent against HDAC7 and 8 [34] . In addition, McCulloch et al. were able to identify psammaplin A as an activator of Wnt signaling in STF3 cells, a cell line in which luciferase is constitutively expressed in response to autocrine Wnt signaling. In this study psammaplin A was comparable in regard to its activity with suberoylanilide hydroxamic acid (SAHA), trichostatin A and MS-275 [35] . In addition to HDAC inhibition, psammaplin A was also characterized as a potent inhibitor of DNA methyltransferases DNMT1 and DNMT3A in A549 and U373MG cell lines with IC 50 values of 7.53 µM in both cases. In this study Kim et al. demonstrated that cell treatment with radiation leads to a significantly reduced cell survival of psammaplin A pretreated cells when compared with untreated controls. γH2AX levels, a marker of DNA double strand break, were observed to be constant over a 12 and 24-hour time course in A549 and U373MG cells, respectively, implying an inhibition of DNA repair mechanisms, due to epigenetic modification caused by psammaplin A [36] .
Interestingly, Mora et al. identified psammaplin A, as an activator of PPARγ in human MCF-7 cells using a luciferase reporter gene assay. Molecular modeling studies additionally suggested an interaction of the compound with the binding site of the PPARγ ligand binding pocket. The EC 50 value was determined to be 5.7 µM, while the IC 50 for inhibition of cell proliferation/viability was accessed as 5 µM. Thereby psammaplin A may play a role in cell differentiation and in induction of apoptosis through the activation of PPARγ in addition to the described inhibitory effects on HDAC and DNMT [37] . In addition to the described epigenetic and pro-apoptotic effects of psammaplin A in mammalian cells, the compound was also found to inhibit aminopeptidase N (APN), leading to a suppression of angiogenesis and invasion of cancer cells. APN was inhibited by psammaplin A in a non-competitive manner with an IC 50 value of 18 µM, resulting in a suppression of cancer invasion and tube formation of endothelial cells treated with basic fibroblast growth factor, while psammaplins B, C, D, A-1 and C1 caused no inhibition. Treatment of different mammalian cell lines with psammaplin A over 72 h, including HepG2, C8161, BAEC, B16/BL6, HT29 and HT1080 cells resulted in IC 50 values between 3 and >30 µM [38] . Studies on DNA replication, using the SV40 DNA replication assay with radiolabeled dTTP, and pol α-primase assay [39] , revealed psammaplin A to inhibit DNA relaxation by inhibition of DNA topoisomerase II with an IC 50 value of 18.8 µM. Parallel evaluation of cytotoxicity of this compound in K549, SK-OV-3, HCT15 and HCT15/CL02 cell lines yielded EC 50 values from 0.39 to 3.76 µM thereby connecting topoisomerase II inhibition with cell death. Interestingly, cells incubated with the MDR modulator verapamil showed a 2.1 fold reduction of the EC 50 value of psammaplin A in HCT15/CL02 cells [40] .
Besides the described effects of psammaplin A towards epigenetic targets such as HDAC, the compound also showed moderate IC 50 (7.0 mM and 70.9 mM, respectively) values with regard to inhibition of farnesyl protein transferase and leucine aminopeptidase (AP-N) [16] , further underlining the diversity of psammaplin A targets. Urbaniak et al. also identified psammaplin A as an inhibitor of the UDP-4Glc4'-epimerase of Trypanosoma brucei TbGaIE as well as mammalian hGaIE with IC 50 values of 15 ± 5.1 and 3.6 ± 0.5 µM, respectively. When evaluating the cytotoxicity against T. brucei and Chinese Hamster CHO-K1 cells EC 50 values of 2.6 ± 2.4 and 0.9 ± 0.6 µM were determined [41] , indicating a non-selective mode of action.
In ecological terms psammaplin A is suspected to act as a fish deterrent [42] and as an antifouling agent [43] . The water soluble psammaplin A sulfate [43] has been shown to be converted to the more lipophilic psammaplin A [42] upon wounding of the sponge. This bioconversion was suggested to be enzymatically catalyzed. Psammaplin A in contrast to its more hydrophilic precursor exhibits significantly stronger antifouling activity [43] , while the fish deterrent effects of both compounds are similar [42] . The authors hypothesized that the stronger antifouling activity of the more lipophilic psammaplin A as compared with its sulfate indicates inhibition of an intracellular target in fouling organisms. In addition to antifouling properties, Ortlepp et al. observed toxicity of psammaplin A to the larvae of B. improvisus with IC 50 values comparable with concentrations needed for inhibition of larval settlement [43] , indicating a non-selective mode of action of the compound with regard to its antifouling properties.
Aerothionin -Aeroplysinin -Dienone -A unique bioconversion cascade involved in sponge chemical defense Aplysina sponges feature a unique and unusual wound-induced bioconversion of bromoisoxazoline alkaloids which gives rise to the nitrile aeroplysinin-1, which is further converted to a dienone ( Figure 2 ) [12, 44] . The latter two compounds which accumulate following wounding of the sponge tissue have previously been shown to be strongly active against several marine bacteria, whereas aerothionin was found to be inactive [12] . Hence, the formation of aeroplysinin-1 and of the dienone has been proposed to be involved in the antibiotic defense of sponges against invading pathogenic bacteria following disruption of the sponge tissue. First indications in favor of an enzymatically catalyzed conversion of aerothionin to the corresponding low molecular weight products aeroplysinin-1 and dienone were given by Teeyapant et al. when observing high amounts of aerothionin when freeze dried sponge samples were extracted in non-aqueous solvents, whereas sponges that were extracted in aqueous solvents yielded large quantities of aeroplysinin-1 and of the dienone instead [12] . Teeyapant and Proksch demonstrated further that treatment of sponge tissue at 90 °C for 5 min prior to extraction inhibited the observed bioconversion of aerothionin to aeroplysinin-1 and the dienone, respectively. Further in situ studies on the conversion of aerophobin-2 and aplysinamisin-1 into the dienone by cell free extracts of A. aerophoba showed a rapid and almost quantitative transformation to aeroplysinin-1 and to the dienone within 40 seconds after mechanical damage of sponge tissue. When using cell free extracts of other non bromoisoxazoline accumulating sponges, boiled extracts of A. aerophoba or assays including known enzyme inhibitors like trichloroacetic acid, no conversion of bromoisoxazoline alkaloids into either aeroplysinin-1 or the dienone was observed [44] . Further evidence for a conversion of bromoisoxazolines by Aplysina sponges was provided by a study of Thoms et al. who reinvestigated the proposed wound induced bioconversion of sponge alkaloids. A. aerophoba was treated in a series of experiments with different disruptive methods thereby injuring the sponge tissue. HPLC analysis of the wounded sponges showed a significant decrease of bromoisoxazolines in damaged sponge tissue, while the amount of aeroplysinin-1 and dienone consistently rose over time. The authors were additionally able to link their observations to the degree of wound induction. Larger disruptions of tissue led to a significantly higher accumulation of aeroplysinin-1 and of the dienone, whereas small damages of sponge tissue caused only minor changes of the alkaloid profiles. It was hypothesized that bromoisoxazoline alkaloids and degrading enzymes are stored in different cellular compartments and are only liberated upon tissue disruption causing the observed bioconversion of sponge alkaloids [45] . Recently Lipowicz et al. characterized a manganese dependent nitrile hydratase isolated from A. cavernicola, which shows a high substrate-specificity for aeroplysinin-1 and converts it into the dienone. De-novo sequencing of the partially purified enzyme by mass spectrometry and comparison with other known nitrile hydratases revealed no homology to known nitrile hydratases, suggesting a unique enzyme to be involved in the alkaloid bioconversion and hence in the chemical defense mechanism of Aplysina sponges [46] . In other Aplysina species, like A. cauliformis and A. archeri, no wound activated conversion of bromoisoxazolines into low molecular weight metabolites was observed [47] . However, since the methods used in the latter study differed from those used for investigating the alkaloid bioconversion in A. aerophoba or A. cavernicola a direct comparison of the results achieved is nevertheless difficult if not impossible.
Aerothionin
Aerothionin, which is one of the bromoisoxazoline alkaloids of the Aplysina defense cascade, was first isolated from A. aerophoba and Verongia thiona in 1970 by Fattorusso et al. [48] and identified as spirocyclichexadienylisooxaolone, suspected to be derived from 3,5-dibromotyrosine and ornithine as a product of an intramolecular phenol-oxime coupling giving rise to a symmetrical dimer [48, 49] . It was speculated that 4-hydroxyphenylpyruvic acid oxime is the biogenetic precursor of aerothionin, since both compounds were isolated from Hymeniacidion sanguinea [50] . Later on, aerothionin was also found in several other Aplysina spp., including A. geradogreeni [51] , A. insularis [47, 52] and A. cauliformis [53] , but also in the Verongid sponges Suberea mollis [54] and Hymeniacidion sanguinea [50] . Therefore aerothionin can be considered as being a chemotaxonomic marker of Verongid sponges [55] . Carney and Rinehart were able to demonstrate through feeding experiments using 14 C-labeled amino acids that the bromotyrosine unit of bromoisoxazoline alkaloids in A. fistularis was derived from phenylalanine, which is subsequently converted to tyrosine [56] . However, the true biosynthetic origin of aerothionin is still questionable, as it is presently unknown whether the compound is derived from the sponge itself or from bacterial symbionts. It was already demonstrated that A. fistularis and A. aerophoba accumulate aerothionin in sphaerulous cells. Although it seems unlikely that microbial metabolites are translocated to the host cell, the hypothesis of a microbial origin could not be rejected [55] . Remarkable in this context is also the observation that aerothionin was found as a secondary metabolite of the crinoid Himerometra magnipinna. Crinoids are not systematically related to sponges which again provokes the question of the actual producer of the compound.
Putz et al. were able to demonstrate that the total amounts of bromoisoxazoline alkaloids in Aplysina sponges show great variability between different sponge individuals collected in the Adriatic Sea. This study revealed also striking differences of alkaloid patterns in different Aplysina specimens, identifying aerothionin as a chemotaxonomic marker of Aplysina sponges allocated at depths > 12 m whereas sponges from more shallow depths were characterized by aerophobin-2 and isofistularin-3 as major constituents instead. Transplantation experiments, through which sponges were moved from deeper sites to more shallow waters and vice versa indicated the bromoisoxazoline alkaloid patterns to be stable over a period of 12 months [57] . As shown in a study by Thoms et al. aerothionin acts as a fish deterrent to Blennius sphinx at ecologically relevant concentrations, whereas the bioconversion products aeroplysinin-1 and dienone showed no fish deterrency. When compared with several other sponge species Aplysina spp. were found to be strongly fish deterrent [58] . Feeding experiments involving the pufferfish Canthigaster rostrata indicated aerothionin likewise to act as a feeding deterrent [53] . This deterrent effect, however, was not observed for the marine mollusk Tylodina perversa, which is a specialized predator on Aplysina sponges. Feeding of T. perversa on Aplysina sponges resulted in a sequestration of aerothionin in mantle tissue, egg masses and mucus. It was speculated that sequestration of aerothionin in these vulnerable tissues or in the defensive mucus serves as an acquired chemical defense for T. perverse, whereas the likewise sequestered sponge pigment uranidine provides a perfect camouflage for the mollusks when present on their sponge prey [12, 59, 60] .
Previously, aerothionin was isolated from the Verongid sponge S. mollis, besides several other bromotyrosine derivatives, and evaluated for its antioxidant, antimicrobial and cytotoxic properties. In this study only a weak antibiotic activity of the compound was detected against S. aureus, indicated by a growth inhibition zone of 5 mm in a paper disc diffusion assay [54] . In a further study by
Abou-Shoer et al., aerothinonin caused growth inhibition of
Klebsiella pneumoniae, expressed by an inhibition zone of 3 mm in the paper disc diffusion assay [61] . Hyphae formation of Streptomyces 85E was inhibited by aerothionin at a concentration of 20 µg/disc [62] . Aerothionin was also evaluated against different Mycobacterium strains, including mono-and multi-drug resistant strains of M. tuberculosis. Strains of M. tuberculosis that were mono-resistant towards isoniazid, rifampicin, streptomycin or ethambutol, respectively, proved susceptible towards aerothionin. The respective MIC values amounted to 12.5 µg/mL. In addition, eight clinical isolates of M. tuberculosis with different resistant patterns were also sensitive towards aerothionin, as indicated by MIC values between 6.25 and 25 µg/mL. However, out of eight nontuberculous mycobacterial strains, only three were susceptible to aerothionin, indicating a selective mode of action of the compound against M. tuberculosis [51] .
Aeroplysinin-1
As mentioned above, aeroplysinin-1 is the first detectable bioconversion product of either aerothionin or of other brominated isoxazoline alkaloids such as isofistularin-3 or aerophobin-2. Aeroplysinin-1 has been shown to exhibit diverse biological activities, including antibiotic, cytotoxic, deterrent and antifouling activity, which may be interpreted in terms of the chemical defense reaction of Aplysina sponges explained in more detail above. First isolated in 1972 by Fattorusso et al. from A. aerophoba [63] , aeroplysinin-1 is, like its bromoisoxazoline precursors, taxonomically restricted to the order of Verongid sponges, including Psammaplysilla purpurea [64] , A. fistularis forma fulva [65] , Pseudoceratina crassa [66] , A. aerophoba [67] , A. cavernicola [68] , A. cauliformis [69] , Verongula gigantea [70] and A. caissara [71] . Interestingly the quantity of aeroplysinin-1 was found to be highly variable in a population of Pseudoceratina crassa sponges collected from the same depth and in the same region [66] . As shown in a study by Makarieva et al. involving 25 Cuban sponges, only those belonging to the order Aplysinidae were able to produce brominated tyrosine derivatives. Out of this group, only four, namely Aplysina archeri, Verongula rigida, V. gigantea and Aiolochroia crassa were able to synthesize aeroplysinin-1, but in strikingly different amounts in relation to sponge dry weight [72] . Both reports give further evidence for a bioconversion of sponge alkaloids, as shown for A. aerophoba and A. cavernicola [66] [72] . In a study on environmental conditions that influence the accumulation of aeroplysinin-1 in sponges Kreuter et al. were able to demonstrate that the compound is only produced in the surface tissue of the sponge. Cultivation experiments revealed a positive correlation of aeroplysinin-1 accumulation with regard to UV light and aeration. Sponges cultivated without aeration and UV light were not able to synthesize aeroplysinin-1. Under ideal conditions V. aerophoba (syn. A. aerophoba) was found to be able to produce up to 13.02 mg aeroplysinin-1 per 100 g sponge [73] . Early studies on antibiotic effects of aeroplysinin-1 already reported activity against Staphylococcus albus, Bacillus cereus and B. subtilis, albeit without mentioning conditions of these experiments and MIC values [63] . Weiss et al. were able to demonstrate a strong antibiotic activity of aeroplysinin-1 against Photobacterium phosphoreum with an EC 50 value of 3.45 µM [74] . Furthermore, when evaluating the antibiotic properties of aeroplysinin-1 against several Gram positive and Gram negative bacteria by a paper disc diffusion assay against Alteromonas sp., Cytophaga sp., Moraxella sp., Pseudomonas fluorescens, Serratia plymuthica, Vibrio sp., Vibrio anaguillarum, and Planococcus citreus, growth inhibition zones of 8 and 30 mm at fixed concentrations of 5, 50 and 100 µg/disc were detected. Both Vibrio spp. proved to be most sensitive towards the compound [74] . Aeroplysinin-1 isolated from Suberea mollis additionally displayed antimicrobial activities in a paper disc diffusion assay against S. aureus, P. aeruginosa and K. pneumoniae, with inhibition zones of 9 mm, 11 mm and 7 mm, respectively. Antioxidant activity of aeroplysinin-1 at 1 mg/mL was comparable with vitamin E when tested at equimolar concentrations, evaluated by 1,1-diphenyl-2-picylhydrazyl radical assay (DPPH) [61] . Furthermore, aeroplysinin-1 isolated from A. chiriquensis and A. gerardogreeni collected along the Pacific Coast of Panama, exhibited antiprotozoal activities against chloroquine-resistant Plasmodium falciparum and Trypanosoma cruzi with IC 50 values of 17.7 and 37.7 µM, respectively [75] . These results are supported by Galeano et al. who observed a growth inhibition of intracellular T. cruzi amastigotes at a fixed concentration of 10 µM of aeroplysinin-1 and a severely retarded growth of Plasmodium falciparum at 5 µM [76] .
Aeroplysinin-1 was reported to have cytostatic effects against the cell line L5178Y with an ED 50 value of 0.47 ± 0.04 µM [73] . Furthermore, an almost complete growth inhibition of U-937 cells was observed at a fixed concentration of 20 µM aeroplysinin-1 [76] . Early studies on the mode of action of aeroplysinin-1, using Ehrlichs ascites tumor cells (EAT) and HeLa cells in MTT and clonogenic assays, exhibited IC 50 values of 6.2 ± 0.7 µM and 5.6 ± 0.7 µM, respectively, in continuous incubation over 3 or 4 days, respectively. Incubation for only 2 h led to a drop in IC 50 values to 8.2 ± 1.0 µM (EAT) and 18.8 ± 2.1 µM (HeLa) in the MTT assay and to 37.0 ± 7.0 µM (EAT) and 27.5 ± 3.0 µM (HeLa) in the clonogenic assay. When aeroplysinin-1 was investigated using cells treated with the glutathione depleting agent buthionine prior to aeroplysinin-1 treatment, even lower IC 50 values of 0.7 ± 0.2 to 5.4 ± 1.5 µM were detected. Detailed studies on the metabolism of aeroplysinin-1 in EAT cells treated with 2 mM of aeroplysinin-1 using electron paramagnetic resonance spectroscopy, revealed the formation of its corresponding semiquinone radical, which was assumed to be at least partly responsible for the cytotoxicity of the compound [77] . More detailed analyses of the anti-tumor mode of action of aeroplysinin-1 revealed an interaction of the compound with several enzymes, particularly those involved in angiogenesis. In a variety of experimental systems that simulate the sequential events of the angiogenetic process, treatment with aeroplysinin-1 resulted in strong inhibitory effects on angiogenesis in BAE cells, indicated by an effective concentration of the compound of 0.7 µM. Anti-proliferative effects were observed at higher concentrations with an IC 50 value of 2.1 µM. Capillary tube formation was completely abrogated and an inhibitory effect on the migration capabilities of endothelial cells was observed. Furthermore, aeroplysinin-1 led to a decreased production of matrix metalloproteinase-2 and urokinase in endothelial cells [78] . Using the in vivo chorioallantontoic membrane assay, apoptosis-inducing effects of aeroplysinin-1 were observed. These data indicate that aeroplysinin-1 interferes with key events in angiogenesis [79] . Similar results in BAE cells were published by Córdoba et al., who observed an IC 50 value for aeroplysinin-1 of 29 µM and an MIC of 2 µM for tube formation, giving further evidence for a specific antiangiogenic effect of this natural product [80] . Additional studies on this compound corroborated a directed effect against endothelial cells, using a modified chorioallantontoic membrane assay with monoclonal endothelial markers [81] . A further study, using BAE, HCT-116 and HT-1080 cells, showed again a specific effect of aeroplysinin-1 on endothelial cells, with activation of caspases 2, -3, -8 and -9, as well as a cleavage of apoptotic substrates like poly (ADP-ribose) polymerase and lamin-A. These observations, in combination with dephosphorylation of Bad and mitochondrial cytochrome c release, implicate a relevant role of mitochondria in the apoptotic activity of aeroplysinin-1 [79] . Previously, Martínez-Poveda et al. were able to demonstrate that this effect is not Sponge derived bromotyrosines Natural Product Communications Vol. 10 (1) 2015 225 restricted to BAE cells, but is also present in human endothelial EVLC-2, RF-24, HUVEC and HMEC cells with IC 50 values of aeroplysinin-1 between 2.6 -4.7 µM. More detailed investigations using a gene array assay revealed significant changes in the expression of thrombospondin b1 and monocyte chemoattractant protein-1, which were both down regulated. Western blotting experiments confirmed a down regulation of laterophilin and of the transmembrane domain-containing protein 1, interleukin 1α and matrix metalloproteinase 1. Treatment of THP-1 monocytes as well as HUVEC cells with aeroplysinin-1 resulted in a significantly reduced expression of cyclooxygenase-2 [82] . Kreuter et al. were able to prove inhibition of phosphorylation of lipocortin-like proteins by purification of EGF receptor-tyrosine kinase complex from MCF-7 breast carcinoma cells in the presence of aeroplysinin-1 at a concentration of 0.5 µM. MCF-7 cells lost their ability to EGF-mediated cell response in the presence of aeroplysinin-1. These effects were found to be reversible after removal of the compound, and selective to carcinoma cells [83] .
In contrast to its biogenetic precursor aerothionin, no fish deterrent effects were observed for aeroplysinin-1 against B. sphinx [58] , whereas aeroplysinin-1 showed a deterrent effect towards the polyphagous marine gastropod Littorina littorea, with an EC 50 value of 0.1 mM [74] . Deterrency of the compound was also detected against the common Caribbean wrasse Thalassoma bifaciatum [44] . Feeding experiments involving the mollusk predator T. perversa that feeds on Aplysina sponges showed sequestration of aeroplysinin-1, similar to the likewise sponge-derived aerothionin. In this study an enrichment of several bromotyrosine alkaloids, including aeroplysinin-1, was observed, particularly in egg masses of the mollusk [60] , underlining the presumed ecological defensive role of the compound. Furthermore, aeroplysinin-1 exhibited a strong growth inhibition against the marine microalgae Coscinodiscus wailesii and Prorocentrum minimum with IC 50 values of 5.6 µM [74] .
Dienone
This bioconversion product (syn. verongiaquinol [84] ) of aeroplysinin-1 was first isolated in 1967 [85] , but was later also found in other Verongid sponges including Verongia cauliformis and V. fistularis [86] . Along with the discovery of the compound its antibiotic potential was recognized [85] . Later on, more detailed studies revealed the antibiotic properties of the dienone to be comparable with those of aeroplysinin-1 showing effects against several Gram positive and Gram negative bacteria in a paper disc diffusion assay against Alteromonas sp., Cytophaga sp., Moraxella sp., Pseudomonas flourescens, Serratia plymuthica, Vibrio sp., V. anaguillarum, and Planococcus citreus, with growth inhibition zones of 7 and 28 mm at fixed concentrations of 5, 50 and 100 µg/disc. The tested Vibrio spp. turned out to be the most sensitive to both compounds [74] .
In addition to its antibiotic effects the dienone also showed promising cytotoxic activity. Early studies on the mode of action using Ehrlich's ascites tumor cells and HeLa cells in MTT and clonogenic assays revealed IC 50 values of the dienone of 26.2 ± 4.1 µM and 15.6 ± 0.6 µM, respectively, during continuous incubation. An incubation for only 2 h led to a decrease of IC 50 values to 46.1 ± 1.8 µM and 15.6 ± 0.6 µM in the MTT assay and 74.3 ± 3.7 µM and 58.0 ± 10.9 µM in the clonogenic assay. When cells were pretreated with the glutathione depleting agent buthionine, the effect of the dienone was more pronounced, as indicated by lower IC 50 values of 3.9 ± 1.10 to 15.7 ± 0.5 µM, which were comparable with those of aeroplysinin-1 in the same assay. Electron paramagnetic resonance spectroscopy revealed the formation of its corresponding semiquinone radical, similar to aeroplysinin-1. The semiquinone radical was assumed to be at least partly responsible for the observed cytotoxicity of the dienone [77] . Using a clonogenic GM-CFC/HALO® assay and comparing the cytotoxicity of the dienone with synthetic structural analogues a significant cytotoxicity of this compound was monitored at a dose of 10 µM. Synthetic derivatives, based on non-radical producing phenolic structures did not show this effect [87] , confirming the previous results. In addition to cytotoxic effects, Gorshkov et In an ecological perspective, the dienone, like aeroplysinin-1, can be viewed as a broad spectrum wound protecting agent. Beside its cytotoxic and antibiotic properties it inhibits the growth of the marine microalgae Coscinodiscus wailesii and Prorocentrum minimum with an IC 50 value of 27.9 µM [74] and of Phytobacterium phosphoreum with an EC 50 value of 1.37 µM [74] . However, a fish deterrent effect was not reported for this compound [58] .
Bastadins -Antifouling agents, regulators of cellular Ca

2+
homeostasis and potential anticancer drug candidates Until now, twenty-six different bastadin derivatives have been reported from marine sponges belonging to the genera Ianthella, Psammaplysilla and Dendrilla (all of them from the Demospongiae) [89] . Chemically these metabolites consist of two brominated tyrosine and two brominated tyramine units. Peptidic condensation of the amino acids with their corresponding amines and further oxidation of the α-amino units yielding oxime functionalities, leads to pivotal intermediates of the bastadin biosynthesis, called hemibastadins. Dimerization of hemibastadins via direct carboncarbon-aryl linkages or arylether bonds results in either open chain or macrocyclic bastadins, the latter being more common. Recently, we have shown that even trimeric hemibastadin congeners, the so called sesquibastadins, occur in the Pacific sponge Ianthella basta [90] . We were also able to prove that the distribution of bastadins within the sponge I. basta is not restricted to sponge cells, but rather extends to the sponge skeleton as well [15] . Bastadins that are associated with sponge skeletons, which mainly consist of chitin composed collagenous spongin [91] as recently shown for I. basta [15] , presumably interact with chitinases, as found for other bromotyrosines like psammaplin A [29] . Thus, it may be speculated that bastadins are involved in inhibition of sponge skeletal degradation by e.g. fungal chitinases [15] .
The facts that genes of flavin-dependent halogenases, enzymes which are presumably responsible for the incorporation of bromine into the aromatic moieties of bastadins, are known from sponge symbionts [15] , and the occurrence of bastadin-like metabolites, called lithothamnins, in the red alga Lithothamnion fragilissimum [92] , suggest that bastadin type compounds may perhaps either be of symbiotic origin or that symbionts are involved in the biosynthesis of bastadin type compounds.
Several pronounced biological activities of bastadins have been elucidated in the last decade. Ortlepp et al. [43] were able to show that bastadins-3, -4, -9 and -16, as well as their putative biogenetic precursor hemibastadin-1, inhibited the settlement of Balanus improvisus cyprid larvae, which are among the major macrofouling organisms. The active concentrations of the tested bastadin derivatives were in the range of 1 to 10 µM. Several synthetic analogues of hemibastadin-1, such as 5,5'-dibromohemibastadin-1 (DBHB), exhibited likewise strong inhibitory effects on the settlement of the cyprids at concentrations that were in the same order of magnitude as observed for the naturally occurring compound. The likewise synthetic debromo-hemibastadin-1, which 226 Natural Product Communications Vol. 10 (1) 2015 Niemann et al.
lacked the bromine substitution of the naturally occurring hemibastadin-1, showed in comparison a less pronounced inhibitory effect, with a minimum dose needed for inhibition of larval settlement of 100 µM, indicating that bromine substitution of the aromatic rings enhances the antifouling activity, but is not an essential structural requirement. Further structure-activity studies pointed to the α-hydroxyimido moiety of hemibastadin type compounds as the prime pharmacophoric substructure. Synthetic hemibastadin derivatives, such as tyrosinyltyramide that lack the α-hydroxyimido moiety, showed no effect on cyprid settlement thus revealing this functionality to be essential for antifouling activity.
Similar structure-activity-relationships for hemibastadins were concluded in a study by Bayer et al. [93] who determined the inhibitory activity of various synthetic hemibastadin analogues towards the phenoloxidase of the blue mussel Mytilus edulis. This Cu 2+ -depending enzyme is considered to play a crucial role in oxidative processes that crosslink phenolic residues in the mollusc foot proteins (Mefp), a key mechanism in the formation of bioglue in byssal threads [94] . The oxime in the α-position to the amide substituent in hemibastadin derivatives was shown to be the decisive structural element needed for the formation of a stable Cu 2+ -complex, indicating that enzyme inhibition, which in turn prevents attachment of blue mussels to a given substrate, is probably caused by chelation of the bivalent metal ions in the active binding side of the phenoloxidase. The significance of an oximemoiety with regard to antifouling properties of marine-derived natural products has also been demonstrated for other spongederived metabolites like diterpenoid alkaloids from Agelas species [95] . In summary, (hemi-)bastadins constitute interesting antifouling compounds of sponge origin that suppress settlement of cyprids, probably by targeting phenoloxidases that are involved in the formation of the adhesive proteins that guarantee a firm attachment of macrofouling organisms to a given substrate.
Mack et al. [96] showed that bastadin-5 and several other derivatives are selective modulators of the Ca 2+ -release channel of the skeletal sarcoplasmic reticulum (SR) ryanodine receptor 1 (RyR-1). A full agonism and specificity for the skeletal isoform of RyR-1 was shown, while affinity for the cardiac receptor isoform was significantly lower. Furthermore bastadins-20, -15, 34-Odisulfatobastadin-7 and 10-O-sulfatobastadin-3 isolated from Ianthella basta showed moderate differential activity as SR Ca 2+ channel agonists of the RyR-1 FKBP12 complex, with EC 50 values of 20.6, 100 and 13.6 µM [97] . In a further study focusing on the effect of bastadins on Ca 2+ homeostasis, Chen et al. [98] showed that naturally occurring bastadin-10 stabilizes primarily the open conformation of the RyR-1 channel and sensitizes the channel for activation by Ca 2+ to an extent that it essentially eliminates regulation in the physiological range of this ion. In later structureactivity studies Zieminska et al. [99] demonstrated that bastadin-10 and several synthetic bastadins produce an effect identical to that observed for RyR-1 in primary cultures of rat cerebellar granule neurons expressing the RyR-2 (cardiac) subtype. Synthetic bastadin-5 released Ca 2+ from the endoplasmatic reticulum (ER) of neurons in a ryanodine-sensitive way. It was further found that these effects are closely related to the excess of aromatic bromination of the bastadins, since a bisdebromo analogue of bastadin-10 (BAST218F6) completely lacked the ability to modulate intracellular Ca 2+ levels. Further studies by Zieminska et al. [100] indicated that structurally simplified open-chain half bastadins, in particular compounds that carry a dibromocatechol ether moiety,, as found in bastadin-5 ("western part") (Figure3), are imitating the activity of naturally occurring bastadins on Ca 2+ homeostasis in cultured rat cerebellar granule neurons. Cytotoxic and antineoplastic properties of bastadins have been rather intensively investigated so far. The first report on the cytotoxic activity of bastadins was by Miao et al. [101] , which described the cytotoxic potential of bastadins-8 and -9 against the L-1210 leukemia cell line with ED 50 values of 4.9 µM. Carney et al. to angionesis. Anti-angiogenic properties of bastadin-6 based on a specific induction of apoptosis in human umbilical vein endothelial cells (HUVEC) were reported by Aoki et al. [105] . Mechanistically, the authors hypothesized an interaction of bastadin-6 with RyR-3, which may result in a mobilization of intracellular Ca 2+ and therefore trigger apoptosis. In a continuative study with synthetic analogues of bastadin-6 Kotoku et al. [106] pointed to the oxime function and to the bromination of the aromatic rings as key structural elements with regard to the anti-proliferative effects of bastadin derivatives against HUVECs and KB3-1 cells. Derivatives where the oxime was masked lacked activity suggesting this moiety to be essential for the formation of hydrogen bond(s) with its target protein and therefore for its anti-angiogenic activity. Changes in the bromination pattern resulted likewise in decreasing activity and/or specificity towards the investigated endothelial cell line. Recently, we have shown that the synthetic hemibastadin derivative DBHB exhibits both in vitro anti-angiogenic effects against HUVECs and anti-migratory effects in mouse B16F10 melanoma cells [107] . In in vivo experiments DBHB, however, failed to increase the survival of B16F10 melanoma-bearing mice, which we suspected to be due to strong binding of the compound to serum albumin. The aforementioned bastadin like lithothamnins, which show meta-meta linkages between the aromatic rings, that have so far not been reported from sponges, also showed moderate cytotoxic properties, as demonstrated for lithothamnin A [92] . This compound exhibited antiproliferative activities against five human tumor cell lines, LOX (IC 50 
Discussion and outlook
This review highlights the ecological importance and pharmacological potential of selected bromotyrosine derivatives from marine sponges. All natural products presented here are assembled from bromotyrosine building blocks involving few enzymatically catalyzed reactions that give rise to a range of structural modifications. The resulting compounds, such as the psammaplins, the bastadins and the Aplysina alkaloids, have been shown to be involved in the chemical defense of sponges against predatory fish, fouling organisms or against pathogenic bacteria. Thus, these compounds are part of the remarkable ecological success of these sessile and potentially vulnerable marine invertebrates that has enabled marine sponges to thrive, even in the most stress prone marine habitats that are characterized by intense predation, such as coral reefs [108, 109] . As shown for psammaplin A and its sulfated precursor [43] , as well as for the bromoisoxazoline alkaloids of Aplysina sponges that are converted to aeroplysinin-1 and a dienone [45, 58] , the chemical defense of sponges may be highly dynamic involving a rapid and efficient enzymatically catalyzed conversion of either inactive or less active storage compounds into highly active defense metabolites. Whereas the former are constitutively present in sponge cells the latter are only formed when and where needed, usually at the site of wounding. As shown for the bioconversion cascade in A. aerophoba and A. cavernicola, this transformation of sponge alkaloids leads to the formation of toxic products that show a multitude of biological activities. Aeroplysinin-1 and the corresponding dienone are not only strong antibiotics that rival even the well-known standard antibiotic chloramphenicol (in fact the dienone had been proposed to be used in aquaculture due to its strong antibiotic activity towards economically important bacterial pathogens [44] ), but both compounds also show pronounced cytotoxic effects in eukaryotic cells making them broad spectrum toxins. Whereas this nonselective activity towards prokaryotes and eukaryotes alike is a problem for drug development it represents a very effective defense strategy in an ecological perspective. Broad-spectrum defense metabolites like aeroplysinin-1 and the dienone that act against prokaryotes and eukaryotes alike can be expected to cope successfully with a diversity of aggressors/invaders whereas highly selective defense compounds would not. The same strategy can also be found in other organisms like in terrestrial plants where wounding of plant tissue leads to hydrolysis of cyanogenic glycosides and the formation of toxic HCN. HCN will not only poison invading herbivores or microbes, but will also kill plant tissue at the site of wounding [110] . This can also be expected for the Aplysina defense metabolites aeroplysinin-1 and dienone, even though direct toxic effects of these compounds on sponge cells have yet to be demonstrated. Since sponges like plants are able to regenerate tissue losses to a large extent this kamikaze attack on invaders can be compensated, whereas it would be detrimental to more highly evolved animals that lack this regenerative capacity.
Even though the bromotyrosine metabolites discussed in this review have all been described from sponges it is by no means clear whether sponges are in all cases also the true producers of these compounds. Sponges are filter feeders and are known to sequester natural products through the food chain, as shown for okadaic acid [111, 112] . On the other hand sponges are also hosts to a multitude of microorganisms that live within the tissues of their host organisms [4] . As recently summarized by our group, highly diverse microbial communities can produce cryptic metabolites that are not present in axenic cultures of microbes. These metabolites can arise during competition and under symbiotic conditions when invading or protecting a certain ecological habitat. It is feasible to assume, that these mechanisms which may lead to activation of usually silent gene clusters are not restricted to inter-microbial competition, but may extend also to interactions between higher organisms and microbes. A prominent example of the latter is the production and accumulation of tetrodotoxin in the pufferfish (Fugu vermicularis radiatus) [113] and a xanthid crab (Atergatis floridus) [114] , as a biosynthetic product of the microbial symbiont Vibrio sp. This highly potent neurotoxin is not harmful to the host, but leads to certain death in potential predators, including man.
Regardless of the true biogenetic origin of the discussed bromotyrosines in sponges, the importance of several of these compounds not only for the chemical ecology of sponges but also for the applied side of natural product chemistry is obvious. As demonstrated for the bastadins the antifouling properties of these metabolites are assumed to protect the sponges from epibiontic overgrowth which would be detrimental for a filter feeding organism by obstructing the pores through which a constant flow of water into the sponge body is maintained. For the synthetically derived and structurally more simple hemibastadins like for DBHB the presumed antifouling target is a phenoloxidase. DBHB is believed to act through complexation of copper ions that are present in the catalytic center of the phenoloxidase. The pharmacophoric moiety of DBHB that is responsible for this enzyme inhibition is the alpha-oxime amido functionality that is present in all bastadin-like molecules, including DBHB. As soon as the oxime function is replaced by an amino group the anti-fouling activity and the phenoloxidase inhibition are completely lost, as shown for synthetic DBHB analogues. The bromine substituents of the aromatic rings enhance the antifouling activity (as well as the inhibition of the phenoloxidase), but are, in contrast to the alpha-oxime amido functionality, not essential structural requirements. However, bastadins do not only show antifouling activity but have also been demonstrated to possess antiangiogenic properties making them interesting for cancer chemotherapy. The antiangiogenic mode of action for bastadin-6 relies on modulation of cytoplasmatic Ca resulting in a release of Ca 2+ from the sarcoplasmatic reticulum, followed by induction of apoptotic processes in cancer cells. The alpha-oxime amido function and a specific aromatic bromination pattern were also, in this case, identified as essential structural features with regard to the antiangiogenic potential of the compounds. These structure activity requirements are very similar to those elucidated for the antifouling activity of DBHB. Since copper ions have been shown to be important for angiogenesis [115] an interaction of bastadins with copper, as shown for DBHB before, [93] is a hypothesis for the mode of the antiangiogenic activity of bastadin-6.
A further example of sponge-derived bromotyrosine derivatives is psammaplin A and its sulfated precursor. Psammaplin A not only shows antifouling activity but was also identified as an important regulator of cellular processes which act through inhibition of generegulating enzymes like HDAC and DNMT. The interaction with these transcription factors leads to epigenetic modifications as known for other epigenetic modifiers such as suberanilohydroxamic acid (SAHA), which, for example, is used in microbial cultures to activate silent biosynthetic gene clusters [116] . It is possible that psammaplin A is involved in regulating biosynthetic pathways of sponge symbionts, even though no studies have been conducted in this direction so far. However, epigenetic regulations can also cause cell death and may therefore contribute to an unspecific antimicrobial activity of a bouquet of sponge-derived compounds to which an invading microorganism is exposed. Histone deacetylases and DNA methyl transferases also represent relevant molecular targets for anticancer research. Due to its pronounced activity against the latter enzymes psammaplin A may also be a future drug lead for anti-cancer chemotherapy, especially since structural modification has been shown to increase considerably the activity of the derivatives compared with the parent compound. Baud et al. demonstrated that the affinity of synthetic psammaplin A derivatives towards HDAC 1 and HDAC 6 could be improved by a factor of 45 and 3.4, respectively [117] . Replacing the obromophenol moiety of psammaplysin A by a 5-bromoindol function improved not only the inhibitory activity of the derivative towards HDAC and DNMT but rendered the derivative also active with regard to inhibition of NAD + -dependent SIRT deacetylase enzymes [31] . Further synthetic modification of psammaplin A via substitution with a 3-bromo-phenyl alanine and with a 4`-flourophenyl moiety even shifted the therapeutic application from cytotoxic to antibiotic activity. The therapeutic index, which describes the selectivity of the compound against prokaryotes, was found to shift, when tested against MRSA, from 0.56 for psammaplin A to 37.5 for the synthetic derivative [25] .
The significant changes in activity profiles for various synthetic derivatives of psammaplin A, as discussed above, is a text book example that highlights the power of medicinal chemistry when acting on natural product scaffolds. The latter represent privileged structures [118] that have been shaped through evolution and hence already possess inherent biological activities. Bromotyrosine derived compounds as featured in this review are especially amenable to structural modifications either by nature or by synthetic chemistry due to their relatively simple structures that can be easily mimicked and further structurally expanded through synthetic approaches, as demonstrated for the various compounds discussed in this review.
